Advanced Enzyme Technologies Limited announced its unaudited consolidated financial results for the quarter and half-year ended September 30, 2026. The Board of Directors approved these results, which include both standalone and consolidated figures. The company also addressed requests for reclassification from promoter group to public category shareholders.
Financial Performance Highlights
Advanced Enzyme Technologies Limited convened a Board Meeting on October 31, 2026, to transact significant business, including the approval of the company’s Un-audited Financial Results (Standalone and Consolidated) for the quarter and half-year ended September 30, 2026. The meeting commenced at 10:45 a.m. and concluded at 11:35 a.m.
Reclassification of Promoter Group
The Board also analyzed requests received from members of the promoter group seeking reclassification to public category shareholders, in accordance with Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Details of these requests and the Board’s views have been provided as Annexure – II.
Disclosure and Accessibility
The aforementioned financial results and related documents have been uploaded on the company’s website, www.advancedenzymes.com, for public access. The company expressed its information for the benefit of the public at large.
Auditor’s Review
MSKA & Associates LLP, Chartered Accountants, provided an Independent Auditor’s Review Report on the consolidated unaudited financial results. Their report indicates that based on their review, nothing has come to their attention to suggest that the accompanying Statement, prepared in accordance with Indian Accounting Standards, contains any material misstatement. The report covered the period up to September 30, 2026.
Standalone Financials
The company also released its Standalone Unaudited Financial Results for the quarter and six months ended September 30, 2026. These results detail revenue from operations, other income, expenses, net profit, and comprehensive income. The statement of standalone assets and liabilities as of September 30, 2026, and the statement of standalone cash flow for the six months ended September 30, 2026, were also provided.
Buy-back of Equity Shares
Notes accompanying the financial results indicate that the company’s buy-back of equity shares program, which commenced on August 14, 2026, had bought back 1,713,324 equity shares by September 30, 2026, for a total consideration of Rs 520.77 million. As of October 30, 2026, the company had bought back 2,410,906 equity shares, utilizing Rs 696.96 million, and the buyback program was subsequently closed.
Source: BSE
